Arginine depletion with PEGylated arginine deiminase has been found to dramatically suppress the tumor growth of MYC-driven SCLCs in genetically engineered mouse models and a patient-derived xenograft from a relapsed SCLC patient [184]. Here, MYC is linked to neoplasm.